The Role of GLP-1 in Mediating Glucose Reductions After Bariatric Surgery

Next Previous
Trial Profile

The Role of GLP-1 in Mediating Glucose Reductions After Bariatric Surgery

Recruiting
Phase of Trial: Phase I

Latest Information Update: 05 Apr 2018

At a glance

  • Drugs Exendin 9 (Primary)
  • Indications Hypoglycaemia
  • Focus Pharmacokinetics

    • Most Recent Events

    • 14 Dec 2016 Results (n=16) published in the Diabetologia.
    • 21 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top